KMT2A and leukemia: Because the MLL/AF9 oncogene confers self-renewal potential on HPCs, MLL/AF9-expressing HPCs (MLL/AF9-HPCs) can expand without limit [29, 31], thus enabling us to transfer clonal leukemia-initiating cells into large numbers of recipient mice.